In “Development of Biotherapeutic Cell Lines for Steady Producing,” Ying Huang (senior principal scientist in biologics approach study and development at Merck) reviewed CLD process optimization to assistance a perfusion-lifestyle platform. Such procedure-intense systems progressively are utilized to improve biomanufacturing outputs. That place